My understanding of what is about to unfold is...
The Resapphealth team
* Have collected data from India and US Covid clinics.
* Have been building an algorithm for Covid 19 based on Professor Abeyratne's work.
* Have gathered a board of respiratory experts of Covid 19 from around the world
* Have knowledge of other Covid 19 studies and are aware of the accuracy and short comings of those studies.
* Have an understanding of the accuracy required for a Covid test to be competitive with Rapid Antigen Testing.
* Have just received a patent in China for their techknowledgy, to which Professor Abeyratne has personally thanked the Chinese patent approval system showing great respect.
I asked Brian Leadman if progress on the Covid data had been made.
Brian stated the data will be released "very soon"
I believe that what is required is known.
I believe that the data would not be released if it were not up to speed.
Tony Keating has been very excited for some time.
So have I....
So have a lot of holders...
This is more important than the US trial that was ....
This needs to be on target.
So ...if this data is very good
The world media will be all over this.
If great this will create millions of dollars of free international media for Resapphealth...
This has the ability to shout the name of Resapphealth world wide.
I have no idea where great Covid data will take Resapphealth share price...
But it won't stay at 7 cents...
This is my opinion...
I would just love to know how long "very soon" is...lol....
MB
COVID-19 Instant Screening test, page-620
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #